[ Inside the business ]

CE stock analysis

CE · Celanese Corp

Plastic material, synth resin/rubber, cellulos (no glass). Growing 6%. Keeps 8¢ of every dollar.

Watch: a leadership change, growth that has stopped speeding up.

The future, in 7 questions

Priced in: 0.2× sales in 5 yrs. Evidence: sales +6% · 8¢ profit/$1 · Industrial cybersecurity rising.

01 What's priced in?0.2× sales in 5 yrs
Sales now$9.8B
Needed in 5 yrs$2.0B
Backlog$317M
02 Is the wave rising?Industrial cybersecurity · 8.8×
'20'21'22'23'24'2544
#18 of 20 mentioning it
03 Will customers keep buying?Sales +6%, steady
No customer over 10%
Backlog $317M · under 0.1× salesSales +6%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 8¢ per $1, falling
'21'22'23'24'258¢
Before running costs: 25% → 20%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +0.1%/yrDebt $11.5B
07 What could break it?2 to watch
  • Growth peaked
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth peaked.

Sales growth −2%, +9%, then +6% vs. a year ago. A leadership change was filed on Nov 16.

What could go wrong

Few warning signs.

It has moved 1.0× the market. In the 2008 crisis it fell 79% while the market fell 51%. Debt is heavy.

Speculative check

Not classified.

Not Self-funding because of: debt over 4× operating profit.

What they sell

55% Engineered Materials.

Engineered Materials 55% · Acetyl Chain 45%

Where each dollar goes

8¢ profit.

79¢ to make what it sells, 13¢ on research and overhead, 8¢ left over. Revenue $9.8B in the last 12 months.

Its market

1.1× the economy.

The government expects its industry, chemical manufacturing, to grow 2.2% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 410¢ of each $1 of profit.

Competitive advantage

8 of 10 years.

Returns beat its 5.7% cost of capital in 8 of the last 10 years. Gross margin went from 26% to 20%.

Future bets

1% on research.

$118M a year on R&D. $281M on equipment and buildings.

All figures from Celanese Corp's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.